Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mette Sprauten
Observed names:
M Sprauten,
M. Sprauten,
Sprauten, Mette
Institution:
Oslo University Hospital
Observed institutions:
Oslo University Hospital,
University Hospital of North Norway,
University of Oslo,
University of Massachusetts Boston,
Dana-Farber Brigham Cancer Center,
University of Bergen
show all 6
ORCID:
0009-0008-9569-2500
Observed ORCID:
0009-0008-9569-2500
OpenAlex ID:
A5034503103
Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer
2011
·
Mette Sprauten
, Thomas H. Darrah
, et al.
·
Journal of Clinical Oncology
·
170
Longitudinal Serum Testosterone, Luteinizing Hormone, and Follicle-Stimulating Hormone Levels in a Population-Based Sample of Long-Term Testicular Cancer Survivors
2014
·
Mette Sprauten
, Marianne Brydøy
, et al.
·
Journal of Clinical Oncology
·
96
Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
2018
·
Ann Rita Halvorsen
, Vandana Sandhu
, et al.
·
Acta Oncologica
·
77
PDF
Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors
2015
·
M. Sprauten
, H.S. Haugnes
, et al.
·
Annals of Oncology
·
67
PDF
Real-world data on nivolumab treatment of non-small cell lung cancer
2016
·
O.T. Brustugun
, M. Sprauten
, et al.
·
Acta Oncologica
·
46
PDF
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
2018
·
Line V. Hjelle
, Per O. M. Gundersen
, et al.
·
Acta Oncologica
·
23
PDF
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
2023
·
Hanne Blakstad
, Eduardo Erasmo Mendoza Mireles
, et al.
·
Neuro-Oncology Practice
·
21
PDF
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
2016
·
Line V. Hjelle
, Roy M. Bremnes
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
21
C-reactive protein (CRP) as a predictive marker for immunotherapy in lung cancer.
2016
·
Odd Terje Brustugun
, Mette Sprauten
, et al.
·
Journal of Clinical Oncology
·
16
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
2023
·
Liv Cathrine Heggebø
, Ida Maria Henriksen Borgen
, et al.
·
BMJ Open
·
15
PDF
Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
2021
·
Marta D Switlyk
, Pitt Niehusmann
, et al.
·
Acta Radiologica Open
·
10
1284P MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer
2020
·
E. Felip
, V. Minotti
, et al.
·
Annals of Oncology
·
8
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
2024
·
Hanne Blakstad
, Eduardo Erasmo Mendoza Mireles
, et al.
·
Journal of Neuro-Oncology
·
4
Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer
2024
·
Enriqueta Felip
, Giulio Metro
, et al.
·
European Journal of Cancer
·
3
Astrocytoma ( CNS WHO grade 4), IDH ‐mutant with co‐occurrence of BRAF p. V600E mutation, and homozygous loss of CDKN2A
2023
·
Henning Leske
, Hanne Blakstad
, et al.
·
Neuropathology
·
3
Impact of long-term serum platinum on neuro- and ototoxicity, cardiovascular disease, and hypogonadism in testicular cancer survivors.
2014
·
Line veronika Hjelle
, Roy M. Bremnes
, et al.
·
Journal of Clinical Oncology
·
2
Fatigue in relation to treatment and gonadal function in a population-based sample of 796 testicular cancer survivors 12 and 19 years after treatment.
2014
·
Mette Sprauten
, Hege Sagstuen Haugnes
, et al.
·
Journal of Clinical Oncology
·
2
Testosterone (T), luteinizing hormone (LH), and follicle stimulating hormone (FSH) levels in testicular cancer survivors (TCSs) 11 and 19 years after orchiectomy.
2013
·
Mette Sprauten
, Marianne Brydoy
, et al.
·
Journal of Clinical Oncology
·
1
Reproduction rates prior to diagnosis of testicular cancer: Does the testicular dysgenesis syndrome exist?
2011
·
M. Cvancarova
, J. Oldenburg
, et al.
·
Journal of Clinical Oncology
·
1
Norwegian Consensus Guidelines for Selection of Neuro-oncology Patients to Proton Therapy
2026
·
Liv Cathrine Heggebø
, Tor-Christian Johannessen
, et al.
·
International Journal of Particle Therapy
PDF
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries
2026
·
Liv Cathrine Heggebø
, Taran Paulsen Hellebust
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy
2026
·
Liv Cathrine Heggebø
, Tor-Christian Aase Johannessen
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Radiation-Induced Optic Neuropathy Following Radiation Therapy for a Recurrent Tuberculum Sellae Meningioma: A Case Report
2024
·
Liv Cathrine Heggebø
, Hanne Blakstad
, et al.
·
Applied Radiation Oncology
P03.14.a Dummy Run Quality Assurance Study in the Ongoing Phase 3 Randomized Pro-glio Trial
2023
·
L Heggebø
, T Hellebust
, et al.
·
Neuro-Oncology
PDF
P11.75.b Pseudoprogression in a Real-world Glioblastoma Cohort: Incidence, Management, Prognostic Impact, and Associated Factors
2023
·
H Blakstad
, E E Mendoza Mireles
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
34
Citation count:
586
H-index:
10
I10-index:
11
Year
Topic
Type
